Executive record

Deepak Srivastava, M.D.

Director at Tenaya Therapeutics, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:deepak-srivastava-m-dVersion: public-0As of: 2026-09-28

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

Deepak Srivastava has been President of Gladstone Institutes since January 2018 and is the Robert W. and Linda Mahley Distinguished Professor at the Gladstone Institute of Cardiovascular Disease. He is a Professor in the Departments of Pediatrics and Biochemistry and Biophysics at UCSF and past-president of the International Society for Stem Cell Research. He holds a BS from Rice University and an MD from the University of Texas.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: President · Organization not publishedTNYA DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. TNYA DEF 14A director slate

    sec filing · Source published: Apr 16, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Nominating/Governance, Science/Innovation · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Gladstone Institutes · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Apr 16, 2026 · Retrieved: Apr 25, 2026

    Supports 1 claim
    • Professional Role: Director at Tenaya Therapeutics, Inc. · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Tenaya Therapeutics, Inc. · Claim reviewed: May 16, 2026